Exicure (XCUR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

XCUR Exicure

Watchlist

10.0700
+1.1800+13.27%

Close Jan 17 16:00 ET

10.2100
+0.1400+1.39%

Post 20:01 ET

30.60MMarket Cap-4.99P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Exicure Inc Trading Halted, Volatility Trading Pause
TipRanksJan 17 09:55 ET
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
BenzingaJan 7 07:15 ET
Exicure Secures $8.7 Million in Stock Purchase Deal
TipRanksJan 6 17:17 ET
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
MT NewswiresDec 27, 2024 09:05 ET
Exicure to Acquire GPCR Therapeutics' US Unit
MT NewswiresDec 27, 2024 03:51 ET
Press Release: Exicure, Inc. Partners With GPCR Therapeutics to Fuel New Growth in Biotech
Dow JonesDec 26, 2024 20:08 ET

Comments

101644365

Jan 17 08:55

$Exicure (XCUR.US)$ buy and pump

Stock_Drift

Jan 15 06:17

Pre Market Ticks. 7:26am 1/15

$Quantum Computing (QUBT.US)$ $EZGO Technologies (EZGO.US)$ $Exicure (XCUR.US)$ $Context Therapeutics (CNTX.US)$ $Energy Vault (NRGV.US)$ $Galaxy Payroll (GLXG.US)$ $CLICK Holdings (CLIK.US)$ $D-Wave Quantum (QBTS.US)$ $Li Bang International (LBGJ.US)$ $908 Devices (MASS.US)$ $Safe & Green Development (SGD.US)$ $Oncolytics Biotech (ONCY.US)$ $Helius Medical Technologies (HSDT.US)$ $Millennium Group International (MGIH.US)$ $Vision Marine Technologies (VMAR.US)$ $Safe & Green (SGBX.US)$
📊⚡️📊

Sean Parker

Dec 27, 2024 01:43

watching

$Exicure (XCUR.US)$
Exicure (XCUR) has signed an MOU with GPCR Therapeutics to acquire its US subsidiary, GPCR USA, and collaborate on drug development pipelines. The deal includes technology transfer of GPCR's CXCR4 inhibitor, currently in Phase 2 clinical trials, with an estimated market size of $1-2 billion annually. The acquisition targets multiple myeloma and acute myeloid leukemia (AML) treatments.
The company has secured total funding of $12 million ($8.7M on Dec 24, $2M on Dec 9, ...

NEWS

$Exicure (XCUR.US)$
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
Thursday, 26th December at 8:08 pm
Exicure, Inc. (NASDAQ: XCUR, "Exicure", "the Company")), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. ("GPCR Therapeutics") on December 24, 2024, aimed at the acquisition of GPCR USA, a subsidiary of GPCR Therapeutics, and the technology transfer and collaborative research on GPCR Therapeutics' ongoing drug developm...